PXS — Provexis Balance Sheet
0.000.00%
- £19.94m
- £18.51m
- £1.26m
Annual balance sheet for Provexis, fiscal year end - March 31st, GBP millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 0.864 | 0.379 | 0.189 | 0.708 | 0.893 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0.117 | 0.122 | 0.158 | 0.079 | 0.094 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Current Assets | 1.13 | 0.846 | 0.498 | 1.01 | 1.3 |
| Total Assets | 1.13 | 0.846 | 0.498 | 1.01 | 1.3 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 0.158 | 0.188 | 0.307 | 0.248 | 0.723 |
| Total Long Term Debt | |||||
| Total Debt | |||||
| Minority Interest | |||||
| Total Liabilities | -0.372 | -0.344 | -0.226 | -0.286 | 0.189 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 1.5 | 1.19 | 0.724 | 1.3 | 1.11 |
| Total Liabilities & Shareholders' Equity | 1.13 | 0.846 | 0.498 | 1.01 | 1.3 |
| Total Common Shares Outstanding |